Phenylbutazone Market

Phenylbutazone Market Size, Share & Industry Analysis, By Source (Pharmaceutical Manufacturers (Branded & Generic), Contract Manufacturing Organizations (CMOs), Research-Grade Suppliers) By End-User (Pharmaceutical Industry, Hospitals & Clinics, Research Institutions) and Forecast, 2025-2035

The Phenylbutazone market is projected to grow at a CAGR of 4.0% from 2025 to 2035, driven by its sustained demand in veterinary medicine, especially for equine pain and inflammation management, and its limited but ongoing use in human medicine under strict regulatory oversight. Phenylbutazone is a nonsteroidal anti-inflammatory drug (NSAID) that acts by inhibiting cyclooxygenase (COX) enzymes, thereby reducing prostaglandin synthesis and alleviating inflammation, pain, and fever.

Though largely withdrawn from widespread human use due to safety concerns, Phenylbutazone remains a key therapeutic agent in veterinary medicine, particularly in the treatment of musculoskeletal disorders in horses, such as arthritis, laminitis, and soft tissue injuries. It is also occasionally used off-label in other large animals under veterinary supervision. Its low cost and effectiveness in managing inflammation and pain continue to support its inclusion in veterinary formularies. Regulatory scrutiny, however, limits its use in food-producing animals and human medicine due to risks of agranulocytosis and gastrointestinal complications.

North America leads the Phenylbutazone market due to high expenditures on equine care, a large equestrian population, and well-regulated veterinary drug distribution channels. Europe follows closely, supported by established equine sports industries and stringent veterinary care standards. The Asia-Pacific region is expected to witness moderate growth, particularly in countries with developing veterinary infrastructure and increasing adoption of NSAIDs in animal health. Latin America and Africa show steady growth, aided by expanding livestock and equine populations and improving access to veterinary care

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Phenylbutazone
  • Key Applications & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Market Value & Revenue Analysis
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Source
    • Pharmaceutical Manufacturers (Branded & Generic)
    • Contract Manufacturing Organizations (CMOs)
    • Research-Grade Suppliers
  • Key End-Use Industries
    • Pharmaceutical Industry
    • Hospitals & Clinics
    • Research Institutions
  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Production & Supply Volume
  • Global Production Capacity & Key Manufacturers
  • Production Process & Technological Developments
  • Raw Material Analysis
  1. Trade Analysis (Import & Export)
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America, Middle East, and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Market Share
  • Company Profiles & Key Developments
  • Mergers, Acquisitions & Investments
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is Phenylbutazone?
Phenylbutazone is a nonsteroidal anti-inflammatory drug (NSAID) primarily used to relieve pain and inflammation in animals, particularly horses, for conditions such as musculoskeletal injuries, arthritis, and lameness.
What is the market growth of Phenylbutazone?
The global Phenylbutazone market is projected to grow at a CAGR of 4.0% from 2025 to 2035. The growth is driven by the increasing demand for veterinary NSAIDs, especially in equine medicine, where the need for effective and affordable anti-inflammatory treatments remains significant.
What are the drivers of the Phenylbutazone market?
Key drivers of the Phenylbutazone market include the growing veterinary care sector, especially for equine and livestock animals, where musculoskeletal disorders are common.
Who are the key players operating in the Phenylbutazone market?
Major companies involved in the production and distribution of Phenylbutazone include Zoetis Inc., Boehringer Ingelheim Animal Health, Merck Animal Health, Ceva Santé Animale, and Vetoquinol.
Which region will exhibit the fastest growth in the Phenylbutazone market?
The Asia-Pacific region is expected to show the fastest growth in the Phenylbutazone market due to the expanding livestock population, increasing veterinary care services, and growing equine sports industries in countries like India, China, and Australia.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.